ASSESSMENT OF THE EFFECTIVENESS OF THE USE OF FLUCONAZOLE AS ANTIFUNGAL PROPHYLAXIS IN THE ALLOGENEIC TRANSPLANT OF HEMATOPOIETIC PROGENITORS

被引：0
|
作者：
Revilla Calvo, N. [1 ]
Garcia-Gutierrez, V [1 ]
Herrera, P. [1 ]
Calbacho, M. [1 ]
Chinea, A. [1 ]
Jimenez, A. [1 ]
Fonseca, J. [1 ]
Saavedra, I [1 ]
Lopez-Jimenez, J. [1 ]
机构：
[1] Hosp Univ Ramon & Cajal, Serv Hematol & Hemoterapia, Madrid, Spain
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB-150
引用
收藏
页码：295 / 296
页数：2
相关论文
共 50 条
  • [41] Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis
    Jantunen, E
    Nihtinen, A
    Volin, L
    Juvonen, E
    Parkkali, T
    Ruutu, T
    Anttila, VJ
    BONE MARROW TRANSPLANTATION, 2004, 34 (10) : 891 - 895
  • [42] Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis
    Jantunen, E
    Nihtinen, A
    Volin, L
    Juvonen, E
    Parkkali, T
    Ruutu, T
    Anttila, V
    BONE MARROW TRANSPLANTATION, 2004, 33 : S195 - S195
  • [43] Antifungal prophylaxis with posaconazole versus fluconazole in children with neutropenia following hematopoietic stem cell transplanation
    Pongtanakul, Bunchoo
    Wangkittikal, Chonthida
    Narkbunnam, Nattee
    Sanpakit, Kleebsabai
    BONE MARROW TRANSPLANTATION, 2019, 54 : 553 - 554
  • [44] SEQUENTIAL TREATMENT AGAINST CMV IN A PATIENT SUBJECTED TO ALLOGENEIC TRANSPLANT OF HEMATOPOIETIC PROGENITORS
    Moatassim De La Torre, Y.
    Lopez Fernandez, E.
    Entrena Urena, L.
    Leyva Ferrer, R.
    Moratalla Lopez, L.
    Jurado Chacon, M.
    HAEMATOLOGICA, 2015, 100 : 293 - 294
  • [45] Risk factors for recurrence of invasive fungal infection during secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients
    Liu, F.
    Wu, T.
    Wang, J. B.
    Cao, X. Y.
    Yin, Y. M.
    Zhao, Y. L.
    Lu, D. P.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (03) : 243 - 250
  • [46] Importance of antifungal prophylaxis in patients who received a nonmyeloablative allogeneic PBSC transplant
    Mossad, SB
    Avery, RK
    Bolwell, BJ
    CLINICAL INFECTIOUS DISEASES, 2003, 36 (11) : 1503 - 1504
  • [47] EXPERIENCE IN OUR CENTRE WITH MICAFUNGIN AS ANTIFUNGAL PROPHYLAXIS IN PATIENTS SUBJECTED TO ALLOGENEIC TRANSPLANT
    Verdugo Cabeza De Vaca, Ma V.
    Madrigal Toscano, Ma D.
    Saldana Moreno, R.
    Rubio Perez, V
    Martin Chacon, E.
    Salamanca Cuenca, A.
    Palacio Heidy, Campo J.
    Raposo Puglia, J. A.
    Garzon Lopez, S.
    HAEMATOLOGICA, 2015, 100 : 295 - 295
  • [48] A Retrospective Review of Fluconazole as Antifungal Prophylaxis in the Adult and Pediatric Haploidentical Stem Cell Transplant Population
    Rettew, Andrew
    McBride, Ali
    Anwer, Faiz
    Maher, Keri Renee
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S395 - S395
  • [49] Itraconazole vs. fluconazole for antifungal prophylaxis in allogeneic HSCT recipients: Results of a randomized trial.
    Marr, KA
    Crippa, F
    Leisenring, W
    Hoyle, M
    Balajee, A
    Musher, B
    Boeckh, M
    Corey, L
    BLOOD, 2002, 100 (11) : 215A - 215A
  • [50] Antifungal Prophylaxis with Voriconazole or Itraconazole in Lung Transplant Recipients: Hepatotoxicity and Effectiveness
    Cadena, J.
    Levine, D. J.
    Angel, L. F.
    Maxwell, P. R.
    Brady, R.
    Sanchez, J. F.
    Michalek, J. E.
    Levine, S. M.
    Restrepo, M. I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (09) : 2085 - 2091
12345